oncology

稳定8 故事4来源最后更新: 8/13/2026

最新故事

科学

8/13/2026AI总结

施普林格·自然推出三种纯开放获取医学和生命科学新刊

国际知名科研出版机构施普林格·自然宣布，旗下BMC品牌新推出《免疫肿瘤学》、《纤维化期刊》和《转化与临床神经炎症》三种纯开放获取医学和生命科学期刊，以促进科研与临床合作并加速成果转化。

Paciente curado de câncer de pâncreas: um caso anedótico que desafia a medicina

Edgard de Luna, 50, superou um câncer de pâncreas de forma inesperada. Após tratamento inovador, não apresenta mais doença detectável, um caso raro que está sendo estudado.

4 min read

GSK to Acquire Nuvalent for $10.6 Billion to Boost Oncology Pipeline

新闻资讯

6/10/2026AI总结

GSK to Acquire Nuvalent for $10.6 Billion to Boost Oncology Pipeline

GSK acquires Nuvalent for $10.6B to bolster oncology pipeline with late-stage lung cancer treatments, aiming to offset future revenue drop from losing HIV medicine exclusivity.

Weight-loss drugs may cut cancer risk by 30%, studies suggest

New studies presented at a major oncology conference suggest GLP-1 weight-loss drugs could reduce cancer risk by 30%. Research indicates they may lower the likelihood of developing breast cancer, decrease mortality risk in breast cancer patients, and reduce the spread of various cancers.

Guardian International

4 min read

Daraxonrasib dobra sobrevida de pacientes com câncer de pâncreas metastático

发展中

健康·6/2/2026AI总结

Daraxonrasib dobra sobrevida de pacientes com câncer de pâncreas metastático

Um novo medicamento, daraxonrasib, dobrou a sobrevida mediana de pacientes com câncer de pâncreas metastático em estudo de fase 3, reduzindo o risco de morte em 60% e apresentando baixa toxicidade. Os resultados foram apresentados na ASCO e devem levar à aprovação regulatória nos EUA.

4 min read

发展中

健康·6/1/2026AI总结

Cancer: The Good, The Bad, and The Ugly

Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.

Guardian International

5 min read

Nova droga dobra sobrevida de pacientes com câncer de pâncreas

紧急

健康·5/22/2026AI总结

Nova droga dobra sobrevida de pacientes com câncer de pâncreas

Nova droga oral, daraxonrasib, dobra sobrevida de pacientes com câncer de pâncreas em estágio avançado. Em ensaio clínico, reduziu risco de morte em 60% e oferece esperança onde antes havia poucas opções.

5 min read

Pharmaceutical sector at risk from GLP-1 'bubble effect' as weight loss drugs dominate R&D returns

发展中

Business·5/4/2026AI总结

Pharmaceutical sector at risk from GLP-1 'bubble effect' as weight loss drugs dominate R&D returns

Deloitte research reveals pharmaceutical R&D returns for top 20 companies reached 7% in 2025, the highest in years, driven almost entirely by GLP-1 weight loss and diabetes drugs. However, excluding these assets, returns plummet to just 2.9%. For the first time in 16 years, obesity treatments have surpassed oncology as the largest contributor to late-stage pipeline value, raising concerns about concentrated risk and a potential bubble effect.

CNBC

2 min read